Skip to main content

AbbVie signals beyond the news: 62+ signals from 7 sources

The latest AbbVie signal on this page is from Nov 17, 2026 (Patents): "AbbVie Inc. uses JONES DAY as outside IP counsel." The busiest sources: X (Twitter) (15+), LinkedIn (14) and Glassdoor (13).

Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn

Get AbbVie's live signals in Claude or ChatGPT, or by API

AskWhat changed at AbbVie this week? Use Autobound signals for abbvie.com.
Signals
62+
Sources
7
Last 90 days
46
Latest
Nov 17, 2026

Source: Autobound Signal API · 112 signals tracked for AbbVie · updated

Other signals · latest 10

Latest AbbVie signals by source

62+ signals for AbbVie across 7 sources.

  1. Patents · Patent counsel

    AbbVie Inc. uses JONES DAY as outside IP counsel.

    JONES DAY is the attorney of record on AbbVie Inc.'s recent US patent work, including a grant in 2026-11.

    Law firm
    JONES DAY
    Law firm domain
    jonesday.com
    Matter date
    Nov 17, 2026

    Google Patents

  2. Patents · Patent grant

    AbbVie was granted a patent for improved risankizumab compositions.

    In November 2026 AbbVie patented risankizumab formulations for pharmaceutical use, designed to reduce unwanted proteins, processing additives, and immune reactions.

    Patent title
    Risankizumab compositions
    Grant date
    Nov 17, 2026
    Inventors
    Liqiang Zhou

    Google Patents

  3. Glassdoor · Return to office tension

    Employee expresses dissatisfaction with mandatory return to office policy

    A senior associate in clinical data systems notes that the recent mandate to return to the office is a significant negative factor in their current experience.

    Overall rating
    4.0 of 5
    CEO approval
    86%
    Reviews read
    10
    Review window
    Nov 2, 2026 to Nov 7, 2026

    Glassdoor

  4. Glassdoor · Sales compensation concerns

    Immunology sales staff cite complex and discouraging incentive compensation structures

    One representative reports that the payout curve is disproportionate, with employees losing 40 percent of their target incentive payout after falling only slightly short of their goal.

    Overall rating
    4.0 of 5
    CEO approval
    86%
    Reviews read
    10
    Review window
    Nov 2, 2026 to Nov 7, 2026

    Glassdoor

  5. X (Twitter)

    AbbVie shares expert discussion on migraine's global socioeconomic burden, citing Brazil cost figures.

    #DYK migraine's socioeconomic burden in Brazil alone in 2018 – 2022 was as much as $148.5 billion? Dr. Malina Müller and Dr. Welber Sousa Oliveira discuss the global socioeconomic impact of migraine. Learn more about migraine and the socioeconomic burden: https://t.co/mse6DsDowq https://t.co/0KUh0ULnAs

    Account
    @abbvie
    Views
    1,138
    Likes
    4
    Reposts
    0

    X (@abbvie)

  6. Reddit · Product change

    AbbVie discontinued its Phase 2 solid tumor drug livmoniplimab, tested in combination with budigalimab, citing limited clinical benefit.

    Post: "AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’"

    Subreddit
    r/biotech
    Upvotes
    49
    Comments
    14
    Sentiment
    Negative

    r/biotech

  7. X (Twitter)

    AbbVie invites attendees to booth #221 and a Product Theater presentation on clinical evidence.

    Attending? Stop by booth #221 to meet our team and learn about our Product Theater presentation "Clinical and Real-World Evidence: A Comprehensive Perspective in MDD (adjunctive) Patients and Bipolar I Patients": https://t.co/vBBnE4DCB1 https://t.co/baXHLRjreO

    Account
    @abbvie
    Views
    877
    Likes
    1
    Reposts
    0

    X (@abbvie)

  8. Conference talks

    Kinga Bazior (Team & Leadership Trainer, AbbVie) at Code Europe 2026.

    Conference
    Code Europe 2026
    Date
    Sep 14, 2026
    Location
    Online and Warsaw, Poland
    Topics
    AI engineering, data engineering, platform engineering, Kubernetes

    Code Europe 2026

  9. Podcasts · Tech adoption

    Venture with Grace discusses AbbVie: tech adoption

    "We also work with healthcare, right? So companies like Blue Cross Blue Shield or AbbVie, where we do a number of different things. But one example there would be, how do you automate clinical documentation?"

    Podcast
    Venture with Grace
    Episode
    Frank Petterson, Uniphore CTPO on Enterprise AI and Product Leadership
    Speaker
    Frank Petterson
    Speaker role
    Counterparty

    Venture with Grace

  10. LinkedIn

    Next week, we’ll be at the 44th Annual J.P.

    Next week, we’ll be at the 44th Annual J.P. Morgan Healthcare Conference. Tune in to the live audio webcast of our fireside chat on January 14, available here: https://bit.ly/3N8fbsi $ABBV #JPM26

    Likes
    2
    Tags
    Pharmaceuticals, Investor Relations, Corporate Strategy

    LinkedIn

Showing 10 of 62+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AbbVie with the Signal API

One POST /v1/companies/enrich call with abbvie.com returns AbbVie signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "abbvie.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about AbbVie other signals

What signals does Autobound track for AbbVie besides news and filings?
This page lists 62+ signals for AbbVie from 7 sources: X (Twitter) (15+), LinkedIn (14), Glassdoor (13), Reddit (11), Patents (6), Conference talks (2) and Podcasts (1). Every row is dated, and most link to the post, review or record.
What are people saying about AbbVie online?
The newest posts on this page: Nov 4, 2026, X (Twitter) (X (@abbvie)): AbbVie shares expert discussion on migraine's global socioeconomic burden, citing Brazil cost figures. Nov 3, 2026, Reddit (r/biotech): AbbVie discontinued its Phase 2 solid tumor drug livmoniplimab, tested in combination with budigalimab, citing limited clinical benefit. Nov 3, 2026, X (Twitter) (X (@abbvie)): AbbVie invites attendees to booth #221 and a Product Theater presentation on clinical evidence.
What do employees say about working at AbbVie?
The newest Glassdoor theme on this page, dated Nov 7, 2026: Employee expresses dissatisfaction with mandatory return to office policy. The overall rating in that row is 4.0 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has AbbVie been granted patents recently?
Yes. The newest grant on this page: Nov 17, 2026, Patents (Google Patents): AbbVie was granted a patent for improved risankizumab compositions.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →